Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Dickson

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Molecular Therapy. Methods & Clinical Development|June 9, 2015
A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type IDaniel C Mendez, Alexander E Stover, Anthony D Rangel, et al.
Molecular Genetics and Metabolism|July 27, 2010
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type IPatricia I Dickson, Stephen Hanson, Michael F McEntee, et al.
Plos Pathogens|April 15, 2016
The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected CellsAnna M Gram, Timo Oosenbrug, Marthe F S Lindenbergh, et al.
The Journal of Biological Chemistry|June 24, 2022
Impaired mitophagy in Sanfilippo a mice causes hypertriglyceridemia and brown adipose tissue activationMiguel Tillo, William C Lamanna, Chrissa A Dwyer, et al.
Molecular Genetics and Metabolism|November 25, 2015
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance inductionPriya S Kishnani, Patricia I Dickson, Laurie Muldowney, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
Molecular Genetics and Metabolism|December 24, 2010
Research challenges in central nervous system manifestations of inborn errors of metabolismP I Dickson, A R Pariser, S C Groft, et al.
Science Translational Medicine|December 3, 2010
Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type IAshley D Dierenfeld, Michael F McEntee, Carole A Vogler, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIBShih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Methods & Clinical Development|June 9, 2015
A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type IDaniel C Mendez, Alexander E Stover, Anthony D Rangel, et al.
Molecular Genetics and Metabolism|July 27, 2010
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type IPatricia I Dickson, Stephen Hanson, Michael F McEntee, et al.
Plos Pathogens|April 15, 2016
The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected CellsAnna M Gram, Timo Oosenbrug, Marthe F S Lindenbergh, et al.
The Journal of Biological Chemistry|June 24, 2022
Impaired mitophagy in Sanfilippo a mice causes hypertriglyceridemia and brown adipose tissue activationMiguel Tillo, William C Lamanna, Chrissa A Dwyer, et al.
Molecular Genetics and Metabolism|November 25, 2015
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance inductionPriya S Kishnani, Patricia I Dickson, Laurie Muldowney, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
Molecular Genetics and Metabolism|December 24, 2010
Research challenges in central nervous system manifestations of inborn errors of metabolismP I Dickson, A R Pariser, S C Groft, et al.
Science Translational Medicine|December 3, 2010
Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type IAshley D Dierenfeld, Michael F McEntee, Carole A Vogler, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIBShih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, et al.
Pageof 10